SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-18-008063
Filing Date
2018-04-12
Accepted
2018-04-12 17:06:35
Documents
5
Period of Report
2018-06-06

Document Format Files

Seq Description Document Type Size
1 PRE 14A snss-pre14a_20180606.htm PRE 14A 1031083
2 GRAPHIC g2018041220522746411251.jpg GRAPHIC 3589
3 GRAPHIC g2018041220521932311248.jpg GRAPHIC 2227
4 GRAPHIC g2018041220521966811250.jpg GRAPHIC 2227
5 GRAPHIC g2018041220521964111249.jpg GRAPHIC 1504
  Complete submission text file 0001564590-18-008063.txt   1046070
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-51531 | Film No.: 18752650
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1